Kims Ivf Fertility Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 19-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 19-12-2024
- Company Age 11 Year, 27 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.49 Cr
as on 19-12-2024
- Revenue 192.84%
(FY 2023)
- Profit 20880.70%
(FY 2023)
- Ebitda 257.43%
(FY 2023)
- Net Worth 76.32%
(FY 2023)
- Total Assets 17.67%
(FY 2023)
About Kims Ivf Fertility Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹1.49 Cr.
Govindasamy Rajarathinam, Kalaiselvi Rajarathinam, and Selvaraj Krishnammal serve as directors at the Company.
- CIN/LLPIN
U85100TN2013PTC093877
- Company No.
093877
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Nov 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruchirappalli, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kims Ivf Fertility Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Govindasamy Rajarathinam  | Director | 24-Aug-2016 | Current |
| Kalaiselvi Rajarathinam | Director | 25-Nov-2013 | Current |
| Selvaraj Krishnammal | Director | 25-Nov-2013 | Current |
Financial Performance of Kims Ivf Fertility Centre.
Kims Ivf Fertility Centre Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 192.84% increase. The company also saw a substantial improvement in profitability, with a 20880.7% increase in profit. The company's net worth Soared by an impressive increase of 76.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kims Ivf Fertility Centre?
Unlock access to Kims Ivf Fertility Centre's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Stemcell Transplantation Assisted Reproduction Research Private LimitedActive 8 years 9 monthsGovindasamy Rajarathinam and Kalaiselvi Rajarathinam are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 18 Nov 2023 | ₹4.90 M | Open |
Canara Bank Creation Date: 05 Jun 2014 | ₹1.00 Cr | Open |
How Many Employees Work at Kims Ivf Fertility Centre?
Unlock and access historical data on people associated with Kims Ivf Fertility Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kims Ivf Fertility Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kims Ivf Fertility Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
